Avances en Medicina
Espironolactona versus placebo, bisoprolol y doxazosina para determinar el tratamiento óptimo de hipertensión resistente a fármacos
Spironolactone versus placebo, bisoprolol and doxazosin to determine the optimal treatment for drug-resistant hypertension
Leído
9062
Vecesse ha leído el artículo
1502
Total PDF
7560
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 20 | 4 | 24 |
| 2025 11 | 125 | 19 | 144 |
| 2025 10 | 162 | 15 | 177 |
| 2025 9 | 142 | 17 | 159 |
| 2025 8 | 123 | 11 | 134 |
| 2025 7 | 122 | 4 | 126 |
| 2025 6 | 99 | 8 | 107 |
| 2025 5 | 138 | 1 | 139 |
| 2025 4 | 155 | 7 | 162 |
| 2025 3 | 152 | 3 | 155 |
| 2025 2 | 167 | 9 | 176 |
| 2025 1 | 187 | 2 | 189 |
| 2024 12 | 168 | 11 | 179 |
| 2024 11 | 144 | 12 | 156 |
| 2024 10 | 129 | 8 | 137 |
| 2024 9 | 154 | 3 | 157 |
| 2024 8 | 89 | 6 | 95 |
| 2024 7 | 121 | 4 | 125 |
| 2024 6 | 115 | 6 | 121 |
| 2024 5 | 125 | 7 | 132 |
| 2024 4 | 105 | 6 | 111 |
| 2024 3 | 121 | 8 | 129 |
| 2024 2 | 123 | 14 | 137 |
| 2024 1 | 145 | 19 | 164 |
| 2023 12 | 99 | 25 | 124 |
| 2023 11 | 109 | 26 | 135 |
| 2023 10 | 122 | 33 | 155 |
| 2023 9 | 105 | 17 | 122 |
| 2023 8 | 68 | 19 | 87 |
| 2023 7 | 113 | 25 | 138 |
| 2023 6 | 108 | 10 | 118 |
| 2023 5 | 113 | 26 | 139 |
| 2023 4 | 93 | 26 | 119 |
| 2023 3 | 105 | 31 | 136 |
| 2023 2 | 75 | 8 | 83 |
| 2022 1 | 83 | 7 | 90 |
| 2022 12 | 64 | 19 | 83 |
| 2022 11 | 87 | 17 | 104 |
| 2022 10 | 72 | 19 | 91 |
| 2022 9 | 52 | 21 | 73 |
| 2022 8 | 52 | 18 | 70 |
| 2022 7 | 46 | 8 | 54 |
| 2022 6 | 57 | 6 | 63 |
| 2022 5 | 67 | 10 | 77 |
| 2022 4 | 72 | 18 | 90 |
| 2022 3 | 60 | 11 | 71 |
| 2022 2 | 78 | 2 | 80 |
| 2021 1 | 71 | 8 | 79 |
| 2021 12 | 44 | 13 | 57 |
| 2021 11 | 48 | 14 | 62 |
| 2021 10 | 80 | 10 | 90 |
| 2021 9 | 52 | 9 | 61 |
| 2021 8 | 49 | 8 | 57 |
| 2021 7 | 68 | 13 | 81 |
| 2021 6 | 63 | 10 | 73 |
| 2021 5 | 38 | 5 | 43 |
| 2021 4 | 140 | 30 | 170 |
| 2021 3 | 55 | 13 | 68 |
| 2021 2 | 47 | 11 | 58 |
| 2020 1 | 63 | 16 | 79 |
| 2020 12 | 60 | 18 | 78 |
| 2020 11 | 52 | 24 | 76 |
| 2020 10 | 46 | 11 | 57 |
| 2020 9 | 48 | 12 | 60 |
| 2020 8 | 50 | 18 | 68 |
| 2020 7 | 57 | 16 | 73 |
| 2020 6 | 32 | 11 | 43 |
| 2020 5 | 27 | 17 | 44 |
| 2020 4 | 43 | 13 | 56 |
| 2020 3 | 47 | 14 | 61 |
| 2020 2 | 44 | 10 | 54 |
| 2020 1 | 35 | 11 | 46 |
| 2019 12 | 74 | 13 | 87 |
| 2019 11 | 48 | 3 | 51 |
| 2019 10 | 55 | 23 | 78 |
| 2019 9 | 45 | 9 | 54 |
| 2019 8 | 37 | 7 | 44 |
| 2019 7 | 59 | 29 | 88 |
| 2019 6 | 53 | 27 | 80 |
| 2019 5 | 90 | 48 | 138 |
| 2019 4 | 37 | 45 | 82 |
| 2019 3 | 31 | 17 | 48 |
| 2019 2 | 23 | 22 | 45 |
| 2019 1 | 24 | 11 | 35 |
| 2018 12 | 23 | 9 | 32 |
| 2018 11 | 30 | 13 | 43 |
| 2018 10 | 28 | 9 | 37 |
| 2018 9 | 9 | 8 | 17 |
| 2018 8 | 6 | 12 | 18 |
| 2018 7 | 6 | 17 | 23 |
| 2018 6 | 8 | 13 | 21 |
| 2018 5 | 18 | 18 | 36 |
| 2018 4 | 14 | 8 | 22 |
| 2018 3 | 8 | 10 | 18 |
| 2018 2 | 5 | 3 | 8 |
| 2018 1 | 11 | 3 | 14 |
| 2017 12 | 7 | 2 | 9 |
| 2017 11 | 12 | 7 | 19 |
| 2017 10 | 14 | 3 | 17 |
| 2017 9 | 13 | 11 | 24 |
| 2017 8 | 16 | 2 | 18 |
| 2017 7 | 16 | 10 | 26 |
| 2017 6 | 13 | 11 | 24 |
| 2017 5 | 16 | 5 | 21 |
| 2017 4 | 23 | 7 | 30 |
| 2017 3 | 26 | 35 | 61 |
| 2017 2 | 25 | 2 | 27 |
| 2016 1 | 19 | 2 | 21 |
| 2016 12 | 32 | 8 | 40 |
| 2016 11 | 51 | 14 | 65 |
| 2016 10 | 142 | 50 | 192 |
| 2016 9 | 3 | 6 | 9 |
| 2016 8 | 0 | 6 | 6 |
| 2016 7 | 0 | 3 | 3 |
Mostrar todo
